Preclinical trial of a MAP4K4 inhibitor to reduce infarct size in the pig: does cardioprotection in human stem cell-derived myocytes predict success in large mammals?

Basic Res Cardiol · 2021 · PMC8137473 · PMID 34018053

Europe PMC DOI

hedged sentence

0.0562

closest p · 1.1× alpha

0.0562

boldest claim

The sentences

at the threshold of significanceP = 0.0562so close (0.05 < p ≤ 0.1)

3 c): only a very small difference in IS/AAR was seen (82.1 ± 8.6%; 7% less than the vehicle control), at the threshold of significance ( P = 0.0562).

also in 82 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.